MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This Week Last Year in Medtech: Jan. 8-14

Image courtesy of Brian Jackson / Alamy Stock Photo calendar (1).jpg
See what Medtronic, Abiomed, and Dexcom were up to this time last year.

Medtronic to Enter Cardiac Mapping Market Via M&A

The acquisition expands Medtronic's portfolio of advanced cardiac ablation products and accessories, including first-time entry into cardiac mapping and navigation systems.

The Reimbursement Tide May Be Turning for iRhythm

Updated rates posted by Medicare Administrative Contractor Novitas may be a positive sign for the company.

Abbott Doesn't Need M&A to Drive Revenue...

Abbott is sitting on a ton of cash. So how will the company prioritize spending in 2022?

Can Non-Invasive Medical Devices Help Halt Liver Disease?

Vibration-controlled transient elastography (VCTE) technology could be used to detect liver disease early and to monitor interventions. 

ViCentra Closes Series C Funding to Expand Its Insulin Pump in Europe

The proceeds from the $75 million funding will be used for the European launch of the company’s updated Kaleido insulin patch pump system.

First Biopolymer Heart Valve Implanted in Humans Fares Well in Study

After a successful early feasibility study in the United States, the TRIA biopolymer valve will be studied globally, beginning in India.

Roche Taps Glytec for Digital Health Partnership

The partnership will leverage Glytec's insulin dosing support software to address challenges with hospital inpatient blood sugar management.

Medtronic Set to Fully Launch Micra AV TPS in Japan

The Dublin-based company said the device was the world’s smallest pacemaker and it can now treat patients with AV block.

Abiomed's Successful Early Feasibility Results for preCardia Device

The device is designed to improve decongestion in acutely decompensated heart failure (ADHF) patients.

Dexcom Has a Big Year Ahead

In a one-on-one interview with MD+DI, Dexcom CEO Kevin Sayer shares the company's biggest lesson from 2021, expectations for G7, his concerns about the supply chain, and more.

TAGS: Markets
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.